Cargando…

Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series

INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Kenneth, Chen, Amanda LH, Chen, Thomas JH, Downs, B William, Braverman, Eric R, Kerner, Mallory, Savarimuthu, Stella, Bajaj, Anish, Madigan, Margaret, Blum, Seth H, Reinl, Gary, Giordano, John, DiNubile, Nicholas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831833/
https://www.ncbi.nlm.nih.gov/pubmed/20181141
http://dx.doi.org/10.1186/1757-1626-3-54
_version_ 1782178274851422208
author Blum, Kenneth
Chen, Amanda LH
Chen, Thomas JH
Downs, B William
Braverman, Eric R
Kerner, Mallory
Savarimuthu, Stella
Bajaj, Anish
Madigan, Margaret
Blum, Seth H
Reinl, Gary
Giordano, John
DiNubile, Nicholas
author_facet Blum, Kenneth
Chen, Amanda LH
Chen, Thomas JH
Downs, B William
Braverman, Eric R
Kerner, Mallory
Savarimuthu, Stella
Bajaj, Anish
Madigan, Margaret
Blum, Seth H
Reinl, Gary
Giordano, John
DiNubile, Nicholas
author_sort Blum, Kenneth
collection PubMed
description INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave(® )device therapy and program. It has been recently shown in acute animal experiments that the H-Wave® device stimulation induces a nitric oxide-dependent increase in microcirculation of the rat Cremaster skeletal muscle. Moreover, chronic H-wave® device stimulation of rat hind limbs not only increases blood flow but induces measured angiogenesis. Coupling these findings strongly suggests that H-Wave® device stimulation promotes rapid and complete healing without need of expensive surgical procedures. CASE PRESENTATION: We decided to do a preliminary evaluation of the H-Wave(® )device therapy and program in three seriously afflicted diabetic patients. Patient 1 had chronic venous stasis for 6 years. Patient 2 had chronic recurrent leg ulcerations. Patient 3 had a chronic venous stasis ulcer for 2 years. All were dispensed a home H-Wave(® )unit. Patient 1 had no other treatment, patient 2 had H-Wave(® )therapy along with traditional compressive therapy, and patient 3 had no other therapy. For patient 1, following treatment the ulcer completely healed with the H-Wave(® )device and program after 3 months. For patient 2, by one month complete ulcer closure occurred. Patient 3 had a completely healed ulcer after 9 months. CONCLUSIONS: While most diabetic ulcers can be treated successfully on an outpatient basis, a significant proportion will persist and become infected. Based on this preliminary case series investigation we found that three patients prescribed H-Wave(® )home treatment demonstrate accelerated healing with excellent results. While these results are encouraging, additional large scale investigation is warranted before any interpretation is given to these interesting outcomes.
format Text
id pubmed-2831833
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28318332010-03-04 Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series Blum, Kenneth Chen, Amanda LH Chen, Thomas JH Downs, B William Braverman, Eric R Kerner, Mallory Savarimuthu, Stella Bajaj, Anish Madigan, Margaret Blum, Seth H Reinl, Gary Giordano, John DiNubile, Nicholas Cases J Case Report INTRODUCTION: Approximately 15% (more than 2 million individuals, based on these estimates) of all people with diabetes will develop a lower-extremity ulcer during the course of the disease. Ultimately, between 14% and 20% of patients with lower-extremity diabetic ulcers will require amputation of the affected limb. Analysis of the 1995 Medicare claims revealed that lower-extremity ulcer care accounted for $1.45 billion in Medicare costs. Therapies that promote rapid and complete healing and reduce the need for expensive surgical procedures would impact these costs substantially. One such example is the electrotherapeutic modality utilizing the H-Wave(® )device therapy and program. It has been recently shown in acute animal experiments that the H-Wave® device stimulation induces a nitric oxide-dependent increase in microcirculation of the rat Cremaster skeletal muscle. Moreover, chronic H-wave® device stimulation of rat hind limbs not only increases blood flow but induces measured angiogenesis. Coupling these findings strongly suggests that H-Wave® device stimulation promotes rapid and complete healing without need of expensive surgical procedures. CASE PRESENTATION: We decided to do a preliminary evaluation of the H-Wave(® )device therapy and program in three seriously afflicted diabetic patients. Patient 1 had chronic venous stasis for 6 years. Patient 2 had chronic recurrent leg ulcerations. Patient 3 had a chronic venous stasis ulcer for 2 years. All were dispensed a home H-Wave(® )unit. Patient 1 had no other treatment, patient 2 had H-Wave(® )therapy along with traditional compressive therapy, and patient 3 had no other therapy. For patient 1, following treatment the ulcer completely healed with the H-Wave(® )device and program after 3 months. For patient 2, by one month complete ulcer closure occurred. Patient 3 had a completely healed ulcer after 9 months. CONCLUSIONS: While most diabetic ulcers can be treated successfully on an outpatient basis, a significant proportion will persist and become infected. Based on this preliminary case series investigation we found that three patients prescribed H-Wave(® )home treatment demonstrate accelerated healing with excellent results. While these results are encouraging, additional large scale investigation is warranted before any interpretation is given to these interesting outcomes. BioMed Central 2010-02-10 /pmc/articles/PMC2831833/ /pubmed/20181141 http://dx.doi.org/10.1186/1757-1626-3-54 Text en Copyright ©2010 Blum et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Blum, Kenneth
Chen, Amanda LH
Chen, Thomas JH
Downs, B William
Braverman, Eric R
Kerner, Mallory
Savarimuthu, Stella
Bajaj, Anish
Madigan, Margaret
Blum, Seth H
Reinl, Gary
Giordano, John
DiNubile, Nicholas
Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
title Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
title_full Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
title_fullStr Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
title_full_unstemmed Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
title_short Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(® )device therapy: a case series
title_sort healing enhancement of chronic venous stasis ulcers utilizing h-wave(® )device therapy: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831833/
https://www.ncbi.nlm.nih.gov/pubmed/20181141
http://dx.doi.org/10.1186/1757-1626-3-54
work_keys_str_mv AT blumkenneth healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT chenamandalh healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT chenthomasjh healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT downsbwilliam healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT bravermanericr healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT kernermallory healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT savarimuthustella healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT bajajanish healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT madiganmargaret healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT blumsethh healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT reinlgary healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT giordanojohn healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries
AT dinubilenicholas healingenhancementofchronicvenousstasisulcersutilizinghwavedevicetherapyacaseseries